Peptide compliance resources

Practical guidance with the sources attached.

01 / PRODUCT NAMES

Names can communicate claims before the description begins

A product name, slug, collection, image, or adjacent category can contribute to an express or implied health or performance message. Review the entire presentation, not only isolated copy.

02 / HEALTH OUTCOMES

Promises can be explicit or implied

Recovery, weight, performance, wellness, dosage, administration, testimonials, and before-and-after narratives may shape the overall impression even without a direct treatment claim.

03 / ENFORCEMENT EXAMPLES

Why RUO wording may not control intended use

FDA warning letters can illustrate the kinds of public signals the agency identified in specific cases. They are not statutes, certifications, or universal adjudications.

04 / PAYMENT READINESS

What an evidence package can—and cannot—show

A package can document captured pages, completed changes, merchant-provided context, open questions, and review history. It cannot prove legality, safety, truth, or provider eligibility.

05 / USE THE SOURCES

Inspect the current authority and its status

Each guide should link to the official source, identify its class, show the last review date, and disclose when applicability requires qualified review.

Open the source library